Bruce & Co. Inc. trimmed its holdings in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 15.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 138,000 shares of the company’s stock after selling 25,000 shares during the quarter. AbbVie […]
Bruce & Co. Inc. lowered its stake in Fate Therapeutics, Inc. (NASDAQ:FATE – Free Report) by 28.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 143,000 shares of the biopharmaceutical company’s stock after selling 57,000 shares during the period. Bruce & […]
Bruce & Co. Inc. trimmed its stake in shares of Fate Therapeutics, Inc. (NASDAQ:FATE – Free Report) by 28.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 143,000 shares of the biopharmaceutical company’s stock after selling 57,000 shares during the quarter. Bruce & […]
Bruce & Co. Inc. grew its holdings in Personalis, Inc. (NASDAQ:PSNL – Free Report) by 100.0% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 300,000 shares of the company’s stock after acquiring an additional 150,000 shares during the period. Bruce & Co. Inc. […]
Bruce & Co. Inc. raised its stake in shares of Darling Ingredients Inc. (NYSE:DAR – Free Report) by 100.0% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 140,000 shares of the company’s stock after purchasing an additional 70,000 shares during the quarter. Darling Ingredients […]